NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
MilitaryCrisisStrikesFebruaryDiplomaticTrumpOscarNewsDigestTimelineTariffsIranBestWinFundingInfrastructureAdditionalClimateTrump'sGreenlandDaysAnnouncesIranianMajor
MilitaryCrisisStrikesFebruaryDiplomaticTrumpOscarNewsDigestTimelineTariffsIranBestWinFundingInfrastructureAdditionalClimateTrump'sGreenlandDaysAnnouncesIranianMajor
All Articles
Mazda North America CEO on Navigating Trump’s Tariffs
Bloomberg
Published about 6 hours ago

Mazda North America CEO on Navigating Trump’s Tariffs

Bloomberg · Feb 23, 2026 · Collected from RSS

Summary

Mazda is among the global automakers facing renewed pressure after President Trump announced a new 15-percent global tariff. The move raises fresh questions about costs, pricing and demand across the auto industry. Against that backdrop, Mazda is rolling out the all-new CX-5, a key model expected to power its next phase of growth as it navigates volatility and uncertainty. Tom Donnelly, Chief Executive Officer of Mazda North America joined Bloomberg Open Interest to talk about his strategy, and what's next for the automaker. (Source: Bloomberg)

Share this story
Read Original at Bloomberg

Related Articles

Bloomberg35 minutes ago
KKR-Backed Global Medical Response Said to Pick Banks for US IPO

Global Medical Response has selected banks for an initial public offering, according to people familiar with the matter, as the KKR & Co.-backed air and ground emergency medical services company joins a growing list of firms seeking to tap investors.

Bloomberg42 minutes ago
Stocks Fall as Software Weakness, Tariff Risks Weigh | Closing Bell

Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Kristine Aquino, Carol Massar and Emily Graffeo. (Source: Bloomberg)

Bloombergabout 1 hour ago
Canadian Drugmaker Apotex Seeks Up to $730 Million in First-Half IPO

Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as much as C$1 billion ($730 million), according to people familiar with the matter.

Bloombergabout 1 hour ago
Active ETF Market Too Big to Ignore: Spence

Travis Spence, Global Head of ETF at JPMorgan Asset Management joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ" to discuss the intensifying race to bring actively managed ETFs to market. (Source: Bloomberg)

Bloombergabout 1 hour ago
Test Your ETF Knowledge in Our IQ Test

Bloomberg's Joel Weber puts Scarlet Fu and Eric Balchunas to the test on "Bloomberg ETF IQ" in this week's edition of "IQ Test." (Source: Bloomberg)

Bloombergabout 1 hour ago
EA Bondholders Fight Debt Buyback as S&P Casts Ratings Doubt

Some of Electronic Arts Inc. bondholders are banding together to fight a debt buyback plan by the video-game maker, even as S&P Global Ratings cast doubt that the maneuver would ultimately save money for the group taking the company private.